GDE2 abnormally accumulates in intracellular compartments in ALS, ALS/FTD and it is likely that the reduction of GDE2 surface expression underlies its failure in the disease (Nakamura et al, 2021; Westerhaus et al, 2022). The gene discussed is GDPD5; the disease is frontotemporal dementia.